CLOVER HEALTH INVESTMENTS, CORP. /DE
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.9B | $1.4B | $1.3B | $1.1B | $1.5B |
| Operating expenses | $2.0B | $1.4B | $1.5B | $1.4B | $2.1B |
| Operating income | -$85.5M | -$45.7M | -$205.3M | -$286.7M | -$637.0M |
| Interest expense | $0 | $0 | $7,000 | $1.3M | $3.2M |
| Pretax income | -$85.5M | -$43.0M | -$213.4M | — | — |
| Income tax expense | $0 | $0 | $0 | $0 | $0 |
| Net income | -$85.5M | -$43.0M | -$213.4M | -$339.6M | -$587.8M |
| Balance Sheet | |||||
| Cash and equivalents | $78.3M | $194.5M | $122.9M | $103.8M | $300.0M |
| Current assets | $307.9M | $343.1M | $428.0M | $625.0M | $752.5M |
| Total assets | $541.0M | $580.7M | $570.7M | $808.6M | $950.8M |
| Current liabilities | $208.8M | $213.5M | $261.1M | $431.5M | $371.9M |
| Total liabilities | $232.3M | $239.6M | $284.3M | $451.7M | $410.8M |
| Stockholders' equity | $308.7M | $341.1M | $286.4M | $347.7M | $535.4M |
| Cash Flow Statement | |||||
| Cash from operations | -$66.9M | $34.8M | -$144.7M | -$203.9M | -$282.3M |
| Depreciation and amortization | $1.8M | $2.5M | $4.0M | $1.5M | $200,000 |
| Stock-based compensation | $103.7M | $114.3M | $140.9M | $164.3M | $163.7M |
| Capital expenditure | $2.0M | $1.6M | $584,000 | $4.5M | $723,000 |
| Free cash flow | -$69.0M | $33.3M | -$145.2M | -$208.4M | -$283.0M |
| Share repurchases | $18.3M | $1.8M | $0 | $0 | $147,000 |
| Impairments | $0 | $0 | $4.2M | $0 | $0 |
Shares outstanding 526.7M · Free float 0.6%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.